Literature DB >> 34758250

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply.

Jamie Lopez Bernal1, Charlotte Gower1, Nick Andrews1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34758250     DOI： 10.1056/NEJMc2113090

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data.

Authors:  Sarah Mullin; Brent Vander Wyk; Jennifer L Asher; Susan R Compton; Heather G Allore; Caroline J Zeiss
Journal:  PNAS Nexus       Date:  2022-07-01

2.  Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination.

Authors:  Floriana Bonura; Dario Genovese; Emanuele Amodio; Giuseppe Calamusa; Giuseppa Luisa Sanfilippo; Federica Cacioppo; Giovanni Maurizio Giammanco; Simona De Grazia; Donatella Ferraro
Journal:  Vaccines (Basel)       Date:  2022-05-30

3.  Limited Impact of Delta Variant's Mutations on the Effectiveness of Neutralization Conferred by Natural Infection or COVID-19 Vaccines in a Latino Population.

Authors:  Carlos A Sariol; Crisanta Serrano-Collazo; Edwin J Ortiz; Petraleigh Pantoja; Lorna Cruz; Teresa Arana; Dianne Atehortua; Christina Pabon-Carrero; Ana M Espino
Journal:  Viruses       Date:  2021-11-30       Impact factor: 5.048

4.  Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study.

Authors:  Sara Y Tartof; Jeff M Slezak; Laura Puzniak; Vennis Hong; Timothy B Frankland; Bradley K Ackerson; Harpreet S Takhar; Oluwaseye A Ogun; Sarah R Simmons; Joann M Zamparo; Sharon Gray; Srinivas R Valluri; Kaije Pan; Luis Jodar; John M McLaughlin
Journal:  Lancet Reg Health Am       Date:  2022-02-14

5.  Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy.

Authors:  Lissenya B Argueta; Lauretta A Lacko; Yaron Bram; Takuya Tada; Lucia Carrau; André Figueiredo Rendeiro; Tuo Zhang; Skyler Uhl; Brienne C Lubor; Vasuretha Chandar; Cristianel Gil; Wei Zhang; Brittany J Dodson; Jeroen Bastiaans; Malavika Prabhu; Sean Houghton; David Redmond; Christine M Salvatore; Yawei J Yang; Olivier Elemento; Rebecca N Baergen; Benjamin R tenOever; Nathaniel R Landau; Shuibing Chen; Robert E Schwartz; Heidi Stuhlmann
Journal:  iScience       Date:  2022-04-11

6.  From Alpha to Omicron SARS-CoV-2 variants: What their evolutionary signatures can tell us?

Authors:  Robert Andreata-Santos; Luiz M R Janini; Ricardo Durães-Carvalho
Journal:  J Med Virol       Date:  2022-01-08       Impact factor: 20.693

7.  Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis.

Authors:  Dipanjan Ghosh; Debabrata Ghosh Dastidar; Kamalesh Roy; Arnab Ghosh; Debanjan Mukhopadhyay; Nilabja Sikdar; Nidhan K Biswas; Gopal Chakrabarti; Amlan Das
Journal:  Sci Rep       Date:  2022-04-14       Impact factor: 4.379

8.  Effectiveness of third vaccine dose for coronavirus disease 2019 during the Omicron variant pandemic: a prospective observational study in Japan.

Authors:  Tetsuya Akaishi; Shigeki Kushimoto; Yukio Katori; Noriko Sugawara; Hiroshi Egusa; Kaoru Igarashi; Motoo Fujita; Shigeo Kure; Shin Takayama; Michiaki Abe; Akiko Kikuchi; Minoru Ohsawa; Kota Ishizawa; Yoshiko Abe; Hiroyuki Imai; Yohei Inaba; Yoko Iwamatsu-Kobayashi; Takashi Nishioka; Ko Onodera; Tadashi Ishii
Journal:  Sci Rep       Date:  2022-08-10       Impact factor: 4.996

9.  A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs.

Authors:  Zezhong Liu; Jie Zhou; Wei Xu; Wei Deng; Yanqun Wang; Meiyu Wang; Qian Wang; Ming Hsieh; Jingming Dong; Xinling Wang; Weijin Huang; Lixiao Xing; Miaoling He; Chunlin Tao; Youhua Xie; Yilong Zhang; Youchun Wang; Jincun Zhao; Zhenghong Yuan; Chuan Qin; Shibo Jiang; Lu Lu
Journal:  Cell Res       Date:  2022-01-19       Impact factor: 46.297

10.  Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac).

Authors:  Chandima Jeewandara; Suranga Fernando; Pradeep Darshana Pushpakumara; Shyrar Tanussiya Ramu; Achala Kamaladasa; Banuri Gunasekara; Inoka Sepali Aberathna; Heshan Kuruppu; Thushali Ranasinghe; Shashika Dayarathne; Osanda Dissanayake; Nayanathara Gamalath; Dinithi Ekanayake; Jewantha Jayamali; Ayesha Wijesinghe; Madushika Dissanayake; Gayasha Somathilake; Michael Harvie; Saubhagya Danasekara; Deshni Jayathilaka; Helanka Dinesh Kumara Wijayatilake; Nihal Weerasooriya; Chinthaka Kekulandara; Lisa Schimanski; Pramila Rijal; Tiong K Tan; Tao Dong; Alain Townsend; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.